Anti-IL-23 (Tremfya)(Guselkumab biosimilar) mAb, IgG1, Human Humanized, Monoclonal

Product Overview

• Article Name: Anti-IL-23 (Tremfya)(Guselkumab biosimilar) mAb, IgG1, Human Humanized, Monoclonal
• Biozol Catalog Number: ABI-12-2003
• Supplier Catalog Number: 12-2003
• Alternative Catalog Number: ABI-12-2003-100UG
• Manufacturer: Abeomics
• Host: Human Humanized
• Category: Antikörper
• Application: ELISA
• Species Reactivity: Human

Product Description

Tremfya or Guselkumab biosimilar is human immunoglobulin G1 lambda (IgG1lambda) monoclonal antibody, a member of the interleukin inhibitors that selectively block interleukin-23 p19. It usually is important in the treatment of Psoriasis. IL-23 is an inflammatory cytokine responsible for the induction of psoriatic plaque formation. It activates the CD4+ T-helper (Th17) cell pathway. Guselkumab biosimilar developed by Abeomics is for research use only and should not be used in diagnostic procedures.

Product Properties

• Clonality: Monoclonal
• Isotype: IgG1
• Purity: Purified from cell culture supernatant by affinity chromatography

Application Notes

• Application Dilute: ELISA 1:5000-10000, FACS 1:100